SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK
38.13
08-January-25 14:20:14
15 minutes delayed
Stocks
+0.70
+1.87%
Today's range
36.76 - 38.31
ISIN
N/A
Source
NASDAQ
-
Supernus Announces First Quarter 2023 Financial Results
09 May 2023 15:05:45 By Nasdaq GlobeNewswire
-
Supernus to Present at the Bank of America 2023 Health Care Conference
02 May 2023 15:05:34 By Nasdaq GlobeNewswire
-
25 Apr 2023 15:15:00 By Nasdaq GlobeNewswire
-
Supernus Announces Repayment of Convertible Notes
03 Apr 2023 15:05:02 By Nasdaq GlobeNewswire
-
Supernus to Participate in Two Upcoming Investor Conferences
08 Mar 2023 15:05:07 By Nasdaq GlobeNewswire
-
Supernus to Present at the Cowen 43rd Annual Health Care Conference
01 Mar 2023 15:55:45 By Nasdaq GlobeNewswire
-
Supernus Announces Fourth Quarter and Full Year 2022 Financial Results
28 Feb 2023 15:05:33 By Nasdaq GlobeNewswire
-
Supernus Enters Into $150 Million Credit Facility
14 Feb 2023 15:30:00 By Nasdaq GlobeNewswire
-
09 Feb 2023 17:15:05 By Nasdaq GlobeNewswire
-
Supernus to Present at the Piper Sandler 34th Annual Healthcare Conference
22 Nov 2022 16:00:00 By Nasdaq GlobeNewswire
-
Supernus to Present at Two November Healthcare Conferences
08 Nov 2022 16:30:00 By Nasdaq GlobeNewswire
-
Supernus Announces Third Quarter 2022 Financial Results
08 Nov 2022 15:05:02 By Nasdaq GlobeNewswire
-
25 Oct 2022 15:30:00 By Nasdaq GlobeNewswire
-
Supernus Provides Regulatory Update on SPN-830
10 Oct 2022 07:30:00 By Nasdaq GlobeNewswire
-
Supernus to Present at the 2022 Wells Fargo Healthcare Conference
31 Aug 2022 15:00:00 By Nasdaq GlobeNewswire
-
Supernus Announces Second Quarter 2022 Financial Results
04 Aug 2022 15:01:00 By Nasdaq GlobeNewswire
-
25 Jul 2022 16:00:00 By Nasdaq GlobeNewswire
-
Supernus to Participate in the Jefferies Healthcare Conference
02 Jun 2022 15:05:00 By Nasdaq GlobeNewswire
-
Supernus Announces First Quarter 2022 Financial Results
09 May 2022 15:05:01 By Nasdaq GlobeNewswire
-
02 May 2022 15:55:00 By Nasdaq GlobeNewswire